Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-26

Clinical Trial Update: A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO) [Phase 3]

View source ↗

Summary

Phase 3 vehicle-controlled trial investigating topical MOB015B for distal subungual onychomycosis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MOB015B (MOB015B)

Snippet

Sponsor: Moberg Pharma AB | Conditions: Onychomycosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING